Randomized study of once-weekly interferon β-1a therapy in relapsing multiple sclerosis: three-year data from the OWIMS study

Background: Once weekly interferon β-1a for multiple sclerosis (OWIMS) demonstrated modest, but significant, magnetic resonance imaging (MRI) benefit of once-weekly (qw) interferon (IFN) β-1a at 48 weeks, but no significant effect on relapses. Objective: An OWIMS extension permitted assessment of lo...

Celý popis

Podrobná bibliografia

Vydané v:	Multiple sclerosis Ročník 11; číslo 1; s. 41 - 45
Hlavní autori:	Freedman, M S, Francis, G S, Sanders, E ACM, Rice, G PA, O'Connor, P, Comi, G, Duquette, P, Metz, L, Murray, T J, Bouchard, J-P, Abramsky, O, Pelletier, J, O'Brien, F
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Thousand Oaks, CA SAGE Publications 01.02.2005
Predmet:	relapsing multiple sclerosis OWIMS study controlled clinical trial relapse-related outcomes MRI once-weekly dosing randomized interferon β-1a
ISSN:	1352-4585, 1477-0970
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!